Thromboprophylaxis in patients with multiple myeloma

Br J Haematol. 2020 Aug;190(4):493-494. doi: 10.1111/bjh.16731. Epub 2020 May 12.

Authors

Tzu-Fei Wang¹, Aurélien Delluc²

Affiliations

¹ Division of Hematology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH, USA.
² Department of Medicine, Ottawa Hospital Research Institute at the University of Ottawa, Ottawa, Ontario, Canada.

PMID: 32395827
DOI: 10.1111/bjh.16731

No abstract available

Publication types

Comment

MeSH terms

Anticoagulants
Humans
Multiple Myeloma* / complications
Multiple Myeloma* / drug therapy
Primary Prevention
Pyrazoles
Pyridones
Venous Thromboembolism* / etiology
Venous Thromboembolism* / prevention & control

Substances

Anticoagulants
Pyrazoles
Pyridones
apixaban